Does LONCASTUXIMAB TESIRINE Cause Disease progression? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Disease progression have been filed in association with LONCASTUXIMAB TESIRINE (ZYNLONTA). This represents 14.0% of all adverse event reports for LONCASTUXIMAB TESIRINE.
12
Reports of Disease progression with LONCASTUXIMAB TESIRINE
14.0%
of all LONCASTUXIMAB TESIRINE reports
6
Deaths
1
Hospitalizations
How Dangerous Is Disease progression From LONCASTUXIMAB TESIRINE?
Of the 12 reports, 6 (50.0%) resulted in death, 1 (8.3%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LONCASTUXIMAB TESIRINE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does LONCASTUXIMAB TESIRINE Cause?
Pneumonia (8)
Anaemia (7)
Platelet count decreased (7)
Covid-19 (6)
Thrombocytopenia (6)
Gamma-glutamyltransferase increased (5)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)